论文部分内容阅读
作者评估了术前皮下注射促红细胞生成素(EPO)和自体献血(ABD)用于小儿心脏手术的可行性和功效。由于对同种输血风险的关注,使术前ABD成为择期手术的有效辅助手段,它减少同种血暴露的危险,多数医生把它看作是最安全的血液成分。近年来在发展血液回收技术方面作出了巨大努力,使心脏手术可以做到无同种输血。在儿童心脏手术中
The authors assessed the feasibility and efficacy of preoperative subcutaneous injection of erythropoietin (EPO) and autologous blood donation (ABD) for pediatric cardiac surgery. Because of the concern about the risks of allogeneic blood transfusions, preoperative ABD is an effective adjunct to elective surgery, which reduces the risk of exposure to the same blood and is considered by most physicians to be the safest blood component. In recent years, great efforts have been made in the development of blood recovery technology so that cardiac surgery can achieve no blood transfusion. In child heart surgery